Guangdong Taienkang Pharmaceutical Co Ltd (301263)

Currency in CNY
35.24
-1.02(-2.81%)
Closed·
301263 Scorecard
Full Analysis
Net income is expected to grow this year
301263 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
35.1536.41
52 wk Range
12.1342.26
Key Statistics
Bid/Ask
35.24 / 35.24
Prev. Close
35.24
Open
36.25
Day's Range
35.15-36.41
52 wk Range
12.13-42.26
Volume
5.94M
Average Volume (3m)
12.31M
1-Year Change
158.66%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
301263 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Guangdong Taienkang Pharmaceutical Co Ltd Company Profile

Guangdong Taienkang Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China and internationally. The company provides products covering various therapeutic areas, including gender health medicines, ophthalmic medicines, gastrointestinal medicines, Chinese patent medicines and external medicines, and sanitary materials in the forms of tablets, pills, injections, and essential oils; medical technology and technology transfer services; and medical devices. It also operates as an agent for pharmaceutical products; and offers medical and daily cotton swabs, masks, sutures, surgical staplers, vascular clips and clip appliers, etc., as well as non-prescription drugs. The company was formerly known as Shantou Taikang Pharmaceutical Co., Ltd. and changed its name to Guangdong Taienkang Pharmaceutical Co., Ltd. in June 2006. Guangdong Taienkang Pharmaceutical Co., Ltd. was founded in 1999 and is headquartered in Shantou, China.

Employees
1081
Market
China

Compare 301263 to Peers and Sector

Metrics to compare
301263
Peers
Sector
Relationship
P/E Ratio
158.2x30.6x−0.5x
PEG Ratio
−3.96−0.160.00
Price/Book
8.3x3.2x2.6x
Price / LTM Sales
20.8x4.8x3.3x
Upside (Analyst Target)
-11.6%40.3%
Fair Value Upside
Unlock5.3%4.7%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.22%
Dividend Yield
0.57%
Industry Median 1.51%
Annualised payout
0.20
Paid annually
5-Years Growth
-5.39%
Growth Streak

Earnings

Latest Release
May 30, 2025
EPS / Forecast
0.07 / --
Revenue / Forecast
184.66M / --
EPS Revisions
Last 90 days

301263 Income Statement

FAQ

What Stock Exchange Does Guangdong Taienkang Pharmaceutical Trade On?

Guangdong Taienkang Pharmaceutical is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Guangdong Taienkang Pharmaceutical?

The stock symbol for Guangdong Taienkang Pharmaceutical is "301263."

What Is the Guangdong Taienkang Pharmaceutical Market Cap?

As of today, Guangdong Taienkang Pharmaceutical market cap is 14.92B.

What Is Guangdong Taienkang Pharmaceutical's Earnings Per Share (TTM)?

The Guangdong Taienkang Pharmaceutical EPS (TTM) is 0.22.

When Is the Next Guangdong Taienkang Pharmaceutical Earnings Date?

Guangdong Taienkang Pharmaceutical will release its next earnings report on 03 Nov 2025.

From a Technical Analysis Perspective, Is 301263 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Guangdong Taienkang Pharmaceutical Stock Split?

Guangdong Taienkang Pharmaceutical has split 1 times.

How Many Employees Does Guangdong Taienkang Pharmaceutical Have?

Guangdong Taienkang Pharmaceutical has 1081 employees.

What is the current trading status of Guangdong Taienkang Pharmaceutical (301263)?

As of 14 Aug 2025, Guangdong Taienkang Pharmaceutical (301263) is trading at a price of 35.24, with a previous close of 35.24. The stock has fluctuated within a day range of 35.15 to 36.41, while its 52-week range spans from 12.13 to 42.26.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.